Live Breaking News & Updates on Ypersensitivity Blu Ca07987c2040

Stay updated with breaking news from Ypersensitivity blu ca07987c2040. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting

BELLUS Health Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications, today. | February 8, 2023 ....

United States , San Antonio , Health Inc , American Academy Of Allergy , American Academy , Annual Meeting , Presentation Details , Refractory Chronic Cough Populations Enrolled , Cough Associated Diagnostic Journey , Refractory Chronic Cough , Bellus Health Inc Stock Exchange , Press Release , Ypersensitivity Blu Ca07987c2040 ,